Ophthalmic AI-Assisted Medical Decision-Making

NARecruitingINTERVENTIONAL
Enrollment

100,000

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Ocular Diseases
Interventions
COMBINATION_PRODUCT

AI-associated strategy

The intervention in this study involves an AI system that leverages multimodal data fusion to support the clinical decision-making and evaluation of ophthalmic diseases. Patients in the intervention group will undergo standard ophthalmic examinations, with clinical decisions guided by the recommendations generated by the AI system. In contrast, patients in the control group will receive only standard ophthalmic examinations and treatment, without the support of AI-assisted decision-making tools.

Trial Locations (5)

325000

RECRUITING

First Affiliated Hospital of Wenzhou Medical University, Wenzhou

RECRUITING

Second Affiliated Hospital of Wenzhou Medical University, Wenzhou

Unknown

RECRUITING

ZhuHai Hospital, Zhuhai

RECRUITING

The Eye Hospital of Wenzhou Medical University, Wenzhou

RECRUITING

Macau University of Science and Technology Hospital, Macao

All Listed Sponsors
collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Second Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

ZhuHai Hospital

OTHER

collaborator

Macau University of Science and Technology Hospital

OTHER

lead

The Eye Hospital of Wenzhou Medical University

OTHER